Literature DB >> 18637501

Virus entry and innate immune activation.

M K Isaacson1, L K Juckem, T Compton.   

Abstract

Human cytomegalovirus (HCMV) exhibits an exceptionally broad cellular tropism as it is capable of infecting most major organ systems and cell types. Definitive proof of an essential role for a cellular molecule that serves as an entry receptor has proven very challenging. It is widely hypothesized that receptor utilization, envelope glycoprotein requirements and entry pathways may all vary according to cell type, which is partially supported by the data. What has clearly emerged in recent years is that virus entry is not going undetected by the host. Robust and rapid induction of innate immune response is intimately associated with entry-related events. Here we review the state of knowledge on HCMV cellular entry mediators confronting the scientific challenges by accruing a definitive data set. We also review the roles of pattern recognition receptors such as Toll-like receptors in activation of specific innate immune response and discuss how entry events are tightly coordinated with innate immune initiation steps.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18637501     DOI: 10.1007/978-3-540-77349-8_5

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  35 in total

Review 1.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

2.  RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection.

Authors:  Matthew S Miller; Wendy E Furlong; Leesa Pennell; Marc Geadah; Laura Hertel
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

3.  Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin.

Authors:  Ashley E Fouts; Pamela Chan; Jean-Philippe Stephan; Richard Vandlen; Becket Feierbach
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

4.  Onset of human cytomegalovirus replication in fibroblasts requires the presence of an intact vimentin cytoskeleton.

Authors:  Matthew S Miller; Laura Hertel
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

Review 5.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

6.  Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells.

Authors:  Matthew B Reeves; Abagail Breidenstein; Teresa Compton
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

7.  Small interference RNA profiling reveals the essential role of human membrane trafficking genes in mediating the infectious entry of dengue virus.

Authors:  Firzan Ang; Andrew Phui Yew Wong; Mary Mah-Lee Ng; Justin Jang Hann Chu
Journal:  Virol J       Date:  2010-02-01       Impact factor: 4.099

8.  Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Authors:  Annalisa Macagno; Nadia L Bernasconi; Fabrizia Vanzetta; Erica Dander; Antonella Sarasini; Maria Grazia Revello; Giuseppe Gerna; Federica Sallusto; Antonio Lanzavecchia
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

Review 9.  Multifaceted evasion of the interferon response by cytomegalovirus.

Authors:  Emily E Marshall; Adam P Geballe
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

10.  An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation.

Authors:  Farah Bughio; David A Elliott; Felicia Goodrum
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.